MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that on November 14, 2019, before the open of the U.S. financial markets, it will report financial results for the third quarter 2019 and recent corporate progress.
For more information on PhaseBio and to receive PhaseBio’s press releases, please visit the Investors section of the company’s website at https://investors.phasebio.com and register for email alerts.
Source: PhaseBio Pharmaceuticals, Inc., One Great Valley Parkway, Suite 30, Malvern PA 19355
Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.